Cargando…

Comparison of the FDA and ASCO/CAP Criteria for HER2 Immunohistochemistry in Upper Urinary Tract Urothelial Carcinoma

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) is one of the known oncogenes in urothelial carcinoma. However, the association between HER2 and the prognosis of upper urinary tract urothelial carcinoma (UUTUC) has not yet been fully clarified. The aim of this study was to evaluate HER2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Gilhyang, Chung, Yul Ri, Kim, Bohyun, Song, Boram, Moon, Kyung Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pathologists and the Korean Society for Cytopathology 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122728/ https://www.ncbi.nlm.nih.gov/pubmed/27725621 http://dx.doi.org/10.4132/jptm.2016.07.12

Ejemplares similares

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Urothelial Dysfunction and Increased Suburothelial Inflammation of Urinary Bladder Are Involved in Patients with Upper Urinary Tract Urolithiasis – Clinical and Immunohistochemistry Study
por: Jiang, Yuan-Hong, et al.
Publicado: (2014)

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines
por: Press, Michael F., et al.
Publicado: (2018)

ASCO 2018: highlights of urothelial cancer and prostate cancer
por: Pichler, Renate, et al.
Publicado: (2018)

Impact of Modified 2013 ASCO/CAP Guidelines on HER2 Testing in Breast Cancer. One Year Experience
por: Varga, Zsuzsanna, et al.
Publicado: (2015)

Characteristics of HER2-negative breast cancers with FISH-equivocal status according to 2018 ASCO/CAP guideline
por: Kong, Hui, et al.
Publicado: (2022)

Molecular Characterization of Urothelial Carcinoma of the Bladder and Upper Urinary Tract
por: Lee, Ji Yun, et al.
Publicado: (2017)

Establishment of diagnostic criteria for upper urinary tract urothelial carcinoma based on genome-wide DNA methylation analysis
por: Fujimoto, Mao, et al.
Publicado: (2020)

Quantitative assessments and clinical outcomes in HER2 equivocal 2018 ASCO/CAP ISH group 4 breast cancer
por: Gupta, Swati, et al.
Publicado: (2019)

Endoscopic Management of Upper Urinary Tract Urothelial Carcinoma
por: Park, Bong Hee, et al.
Publicado: (2013)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

The Efficacy of Adjuvant Chemotherapy for Locally Advanced Upper Tract Urothelial Cell Carcinoma
por: Kim, Taek Sang, et al.
Publicado: (2013)

Time to change the management of upper urinary tract urothelial carcinoma
por: Akand, Murat, et al.
Publicado: (2020)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Hypercalcemia an exceptional complication in upper urinary tract urothelial carcinoma
por: Jandou, Issam, et al.
Publicado: (2021)

Therapeutic strategies for asymptomatic upper urinary tract urothelial carcinoma
por: Lin, Deng, et al.
Publicado: (2022)

Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
por: Gajate, Pablo, et al.
Publicado: (2020)

Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
por: Crespo, James, et al.
Publicado: (2020)

Impact of the 2018 ASCO/CAP guidelines on HER2 fluorescence in situ hybridization interpretation in invasive breast cancers with immunohistochemically equivocal results
por: Wang, Bo, et al.
Publicado: (2019)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma
por: Zhang, Xiaodi, et al.
Publicado: (2021)

Prognostic factors in laser treatment of upper urinary tract urothelial tumours
por: Niţă, Gh, et al.
Publicado: (2012)

Bladder tumor recurrence after urothelial carcinoma of the upper urinary tract
por: Lonergan, Peter E., et al.
Publicado: (2020)

Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers
por: Smentkowski, Katherine E., et al.
Publicado: (2020)

Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines
por: Nagarjun, B. R., et al.
Publicado: (2022)

Transcriptional Analysis of Immunohistochemically Defined Subgroups of Non-Muscle-Invasive Papillary High-Grade Upper Tract Urothelial Carcinoma
por: Jung, Minsun, et al.
Publicado: (2019)

ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018)

Are urothelial carcinomas of the upper urinary tract a distinct entity from urothelial carcinomas of the urinary bladder? Behavior of urothelial carcinoma after radical surgery with respect to anatomical location: a case control study
por: Kim, Myong, et al.
Publicado: (2015)

RE: Preoperative serum albumin as a prognostic factor in patients with upper urinary tract urothelial carcinoma
por: Ku, Ja Hyeon, et al.
Publicado: (2015)

Radiofrequency-Treated Recurrence of Urothelial Carcinoma of the Upper Urinary Tract After Nephroureterectomy
por: Molina, Roberto, et al.
Publicado: (2014)

Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma
por: Chen, Chung-Hsin, et al.
Publicado: (2016)

Upper Urinary Tract Urothelial Cancer in Croatian and Bosnian Endemic Nephropathy Regions
por: Samardzic, Josip, et al.
Publicado: (2017)

Photodynamic diagnosis in upper urinary tract urothelial carcinoma: A systematic review
por: Osman, Elsawi, et al.
Publicado: (2017)

NFATc1 Expression as a Prognosticator in Urothelial Carcinoma of the Upper Urinary Tract
por: Kawahara, Takashi, et al.
Publicado: (2017)

Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma
por: Metcalf, Meredith, et al.
Publicado: (2020)

Challenging Visualization of Sentinel Lymph Nodes in Upper Urinary Tract Urothelial Carcinoma
por: Polom, Wojciech, et al.
Publicado: (2021)

Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020)

Upper urinary tract urothelial carcinoma diagnosis by biopsy of a vaginal metastasis
por: Hermi, A., et al.
Publicado: (2022)

Prognostic impact of stromal periostin expression in upper urinary tract urothelial carcinoma
por: Miyai, Kosuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qtiiuh18k39q0qds4942r39ttl